Cardiac Prosthetic Devices Market – By Product, By End Use - Global Forecast, 2025 – 2034

Cardiac Prosthetic Devices Market Size

The global cardiac prosthetic devices market size was valued at USD 8.6 billion in 2024 and is expected to exhibit growth at a CAGR of 8.4% from 2025 to 2034. High market growth can be attributed to continuous technological advancements in medical devices, rising prevalence of cardiovascular diseases, growing geriatric population, and increasing adoption of minimally invasive procedures, among other contributing factors.
 

Moreover, the aging population is more susceptible to heart-related ailments, creating demand for cardiac devices. For instance, according to a recent United Nations (UN) research report, the number of people aged 65 and over globally is predicted to triple over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the global population. Elderly patients are often at higher risk for heart valve diseases and may require interventions like heart valve replacements and other cardiac prosthetic devices.
 

Furthermore, innovations in materials, device designs, and minimally invasive implantation techniques have improved the performance and safety of cardiac prosthetic devices. For example, developments in transcatheter aortic valve replacement (TAVR) devices make them suitable for patients who are high-risk for open-heart surgery.
 

Cardiac prosthetic devices are artificial devices implanted in the heart or related cardiovascular structures to replace or support the function of damaged or diseased heart components. These devices are primarily used to treat severe heart conditions or abnormalities that cannot be managed through medication or less invasive treatments.
 

Cardiac Prosthetic Devices Market Trends

The market is experiencing several market trends that are shaping its growth and development. Factors such as increasing adoption of transcatheter heart valve devices, development of durable and biocompatible materials, growing focus on hybrid prosthetic devices, and rising demand for AI and machine learning for improved device design, among other factors, are boosting industry growth.
 

• There is a growing demand for minimally invasive procedures, such as transcatheter heart valve replacement and transcatheter mitral valve repair (TMVR). These methods are less invasive than traditional open-heart surgery, reduce recovery time, and are particularly suited for high-risk or elderly patients who may not be candidates for open surgery.
   
• Additionally, integration of cardiac prosthetics with wearable heart monitoring devices is emerging as a trend. By syncing with patient monitoring systems, prosthetic devices can transmit real-time data, allowing healthcare providers to monitor device performance and patient heart health, and intervene when necessary. These factors are expected to drive the market.
   

Cardiac Prosthetic Devices Market Analysis

Based on product, the market is classified into pacemakers and heart valves. The pacemaker segment generated the highest revenue of USD 5.7 million in 2024.
 

• The rising incidence of arrhythmias, including bradycardia, atrial fibrillation, and heart block, is a major driver for pacemakers. For instance, according to the American Heart Association's 2021 Heart Disease and Stroke Statistics Update, atrial fibrillation affects an estimated 5.2 million Americans, with projections suggesting this number could rise to 12.1 million by 2030. Arrhythmias disrupt the heart's rhythm and require intervention, often in the form of a pacemaker, to regulate heart rate and prevent severe complications.
   
• Moreover, continuous improvements in pacemaker technology have enhanced device functionality, longevity, and safety. Innovations such as leadless pacemakers, MRI-compatible pacemakers, and wireless connectivity are expanding treatment options and improving patient comfort and outcomes, driving market growth.
   

Based on end use, the cardiac prosthetic devices market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 9 billion by the end of the forecast period.
 

• Hospitals are establishing specialized cardiac units, increasing the demand for advanced cardiac prosthetic devices. These units are equipped to perform complex cardiac surgeries and interventions, using prosthetic devices to treat patients with specific needs such as valve diseases or arrhythmias.
   
• Additionally, hospitals are focusing on the long-term cost-effectiveness of treatments. Cardiac prosthetic devices that reduce hospital readmissions, shorten recovery times, and improve patient outcomes are considered valuable investments. For instance, minimally invasive valve replacement techniques and pacemakers that reduce the need for follow-up surgeries can help hospitals optimize patient care while minimizing costs.
   

North America cardiac prosthetic devices market accounted for USD 3.7 billion market revenue in 2024 and is anticipated to grow at a CAGR of 7.7% between 2025 and 2034.
 

• North America, particularly the U.S., faces a high burden of cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias. Lifestyle factors such as poor diet, sedentary lifestyles, and high rates of obesity and hypertension contribute significantly to this. The increasing incidence of these diseases leads to a growing demand for advanced cardiac prosthetic devices like pacemakers and heart valves.
   
• The region is at the forefront of medical technology innovation, with continuous improvements in the design and functionality of cardiac prosthetic devices. Innovations such as leadless pacemakers, MRI-compatible pacemakers, and minimally invasive transcatheter heart valves (TAVR) have significantly enhanced the effectiveness and safety of cardiac treatments. These technological advancements encourage hospitals and healthcare providers to adopt these devices for better patient outcomes.
   

Germany cardiac prosthetic devices market is projected to grow remarkably in the coming years.
 

• Germany has a well-established healthcare system with modern hospitals and specialized cardiac centers. The country is home to several world-renowned medical institutions that are equipped to perform complex surgeries involving cardiac prosthetic devices. The strong healthcare infrastructure supports the widespread use of these devices, ensuring their availability and accessibility to patients.
   
• The country's healthcare system is largely publicly funded through a mandatory insurance scheme, which covers a broad range of medical treatments, including those involving cardiac prosthetic devices. Favorable reimbursement policies for medical procedures that use these devices, such as pacemaker implantation and heart valve replacements, make treatment more accessible to the general population and support hospitals in adopting these technologies.
   

China holds a dominant position in the Asia Pacific cardiac prosthetic devices market.
 

• China has a rapidly aging population due to increased life expectancy and the effects of the one-child policy. As the elderly population grows, the incidence of age-related cardiovascular diseases also rises. Older adults are more prone to conditions such as heart valve diseases and electrical disturbances in the heart, which often require cardiac prosthetic devices like pacemakers and heart valve replacements. The aging population is thus a significant driver of the market.
   
• The country is continuously investing in its healthcare infrastructure, with a focus on improving the accessibility and quality of healthcare services. There has been an expansion of hospitals and specialized cardiac centers across the country, particularly in urban areas. This modernization of the healthcare system is driving the adoption of advanced medical technologies, including cardiac prosthetic devices. Hospitals are increasingly equipped to perform complex cardiac surgeries using the latest devices, which helps to meet the growing demand for treatments involving prosthetic devices.
   

Cardiac Prosthetic Devices Market Share

The market is highly competitive, with major players like Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences Corporation, and Biotronik leading the market. These companies focus on innovation, with advancements in minimally invasive procedures and device technologies such as leadless pacemakers and transcatheter heart valves. Intense competition exists due to the presence of both global and regional manufacturers, driving the continuous development of advanced, cost-effective devices.
 

Cardiac Prosthetic Devices Market Companies

Prominent players operating in the cardiac prosthetic devices industry include:

• Abbott Laboratories
• Abiomed
• AtriCure
• Biotronik
• Boston Scientific Corporation
• CryoLife
• Edwards Lifesciences Corporation
• Labcor Laboratórios
• Lepu Medical Technology
• Lifetech Scientific
• LivaNova
• Medtronic
• Meril Life Sciences
• MicroPort Scientific
• Siemens Healthcare
   

Cardiac Prosthetic Devices Industry News:

• In January 2022, Medtronic plc has announced that they had received the approval from Japan's Ministry of Health, Labor and Welfare for the launch of Micra AV Transcatheter Pacing System (TPS) in Japan. This pacemaker is incorporated with advanced pacing technology and is intended for the treatment of AV block. This approval and product launch helped the company to expand their geographic presence and increase their customer base.
   
• In September 2021, Abbott Laboratories announced that they had received the U.S. Food and Drug Administration (FDA) approval for their Epic Plus and Epic Plus Supra Stented Tissue Valves for the diagnosis and treatment of aortic valve disease. These devices are equipped with advanced radiopaque markers to deliver long-term performance and durability and help improve the quality of life for patients. This regulatory approval helped the company to enhance their R and D capabilities and increase the customer base.
   

The cardiac prosthetic devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Pacemaker
  • Implantable pacemaker
  • External pacemakers
• Heart valves
  • Mechanical heart valve
  • Tissue heart valve
  • Transcatheter heart valve

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE